Table 2 Biomarkers in relation to risk of fatal and nonfatal cardiovascular events, all-cause mortality and decline in eGFR >30%

1.5 (1.2–1.9)

0.001

1.6 (1.2–2.1)

0.001

1.9 (1.3–2.6)

<0.001

1.7 (1.1–2.6)

0.019

2.3 (1.4–3.9)

0.001

2.2 (1.4–3.7)

0.002

1.2 (0.8–1.6)

0.38

1.7 (1.2–2.5)

0.002

1.2 (0.8–1.6)

0.29

1.0 (0.7–1.5)

0.93

1.8 (1.2–2.7)

0.006

1.0 (0.7–1.4)

0.85